Waste Management reported adjusted third-quarter earnings of $2.15 per share, three cents short of both the $2.18 consensus and the Earnings Whisper number, a 1.4% miss. Revenue of $6.846 billion beat the $6.80 billion consensus by 0.7%. Earnings grew 8.6% year over year and revenue rose 6.3%, ahead of the company's 4.6% nine-month pace. That is the central tension: the top line, cash generation and Healthcare Solutions all did their jobs, but costs ate most of the incremental revenue before it reached the bottom line. Adjusted operating EBITDA rose 5.8%, roughly in line with revenue growth, so the operating leverage investors expect from WM's pricing machine did not show up this quarter.

The margin detail explains the miss. Adjusted operating EBITDA margin slipped 10 basis points to 31.0%. Collection and Disposal price-to-cost spread added 40 basis points and Healthcare added 30. Higher fuel took away 40 basis points, and a $63 million year-over-year increase in risk management costs took away another 40. Management tied the risk costs to an adverse actuarial adjustment, large loss claims and a tough insurance-recovery comparison. Operating expenses climbed to 59.8% of revenue from 58.9%, even as SG&A improved 70 basis points to 9.3% on an adjusted basis. GAAP EPS jumped to $2.05 from $1.49, but that comparison mostly reflects lapping last year's $152 million impairment tied to a suspended business. It should not be read as an underlying acceleration.

The call surfaced real improvement alongside persistent softness. Healthcare Solutions, the former Stericycle, posted its first year-over-year revenue growth since the acquisition, up 3.7%. Adjusted EBITDA rose roughly a third, and segment margin widened to 22.4% from 17.5%. Healthcare core price reached 5.5%, up from 4.5% in Q2, and segment SG&A fell to 15.2%, hitting year-end targets a quarter early. Management now expects full synergies by mid-2027. Recycling EBITDA rose about 40% to $91 million on stronger commodity prices, at about $82 a ton versus $68. Renewable energy revenue climbed to $167 million from $115 million. Volume is the weak spot:

• Collection and Disposal volume fell 0.5% on a workday-adjusted basis.
• Commercial volume worsened to about -1.3%, reflecting prior national-account broker losses and soft small-business formation.
• Construction and demolition volume is down about 4.5% year to date on weak housing.
• Special waste projects have been delayed.

Core price of 5.8% is still carrying the story, which leaves growth heavily dependent on pricing discipline.

Guidance carries the most important signal. Revenue and free cash flow are now expected at the high end of their ranges, $26.275-$26.475 billion and $3.75-$3.85 billion respectively. Adjusted operating EBITDA, however, was only reaffirmed within its $8.15-$8.25 billion range. Management guided fourth-quarter margin below the year-ago level and did not reiterate the 31%-31.2% margin target it raised in Q2. Analysts' math on the call pointed toward the lower half of the EBITDA range. Diesel costs remain elevated, with a one-month surcharge recovery lag. RNG production is running below plan on pipeline and startup delays, and capital spending is trending to the high end of guidance. The free cash flow strength, $3.01 billion through nine months and up more than 42%, is genuine but flattered by a sharp drop in sustainability growth capex to $191 million from $429 million. On the positive side, M&A is picking up: about $140 million is expected to close in Q4 and a $250 million solid waste deal has been signed for early 2027. The company also repurchased $580 million of stock in the quarter and remains on track for $2 billion for the year. A CEO transition adds a layer of change, with Jim Fish retiring in early January and John Morris succeeding him with a stated continuity of strategy.

Investor sentiment deteriorated meaningfully heading into the report, falling from 0.25 to essentially neutral at 0.005. Expectations had already cooled before the miss. The stock has gone nowhere since the last report, at $235.81 versus a $236.69 opening price after the July release. Shares sit about 4.8% above the 200-day moving average, and the Earnings Whispers price and AVWAP trend readings remain positive. The market has treated WM as a stable holding rather than a growth story, and this quarter does little to change that.

The bottom line is that WM delivered a quality-of-revenue and cash-flow quarter that fell short on earnings because fuel and insurance costs absorbed its pricing gains. The Healthcare inflection is the most encouraging development since the Stericycle deal. Still, flat margins, a softer fourth-quarter margin outlook, and EBITDA guidance that was merely reaffirmed give bears legitimate ammunition. Until volumes stabilize or cost headwinds ease, the stock's steady technical footing rests more on cash returns than on earnings momentum.